Randomized double-blinded and controlled clinical trial on treatment of HIV/AIDS by Zhongyan-4
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Objective: To assess the efficacy and safety of Zhongyan-4 (ZY-4, a Chinese herbal preparation worked out according to the therapeutic principle of supplementing qi, nourishing Yin, clearing heat and detoxication) in treating HIV/AIDS patients in the early or middle stage.Methods: Adopted was randomized double-blinded and placebo-parallel-controlled method, with 72 HIV/AIDS patients randomly divided into the ZY-4 group (36 patients) treated with ZY-4 and the control group (36 patients) treated with placebo. The treatment course was six months. The index of CD 4 + , CD 8 + counts, body weight, clinical symptom scoring were estimated at 4 time points (0, 1, 3 and 6 month in the course), and also the viral load before and after treatment. The whole course of observation was completed in 63 patients, 30 in the ZY-4 group and 33 in the control group.Results: CD 4 + count in the ZY-4 group got elevated by 7.70 ± 150.96/mm3 on average, while that in the control group lowered by 27.33 ± 85.28 /mm3. Fifteen out of the 30 patients in the ZY-4 group had their CD 4 + count increased, which was evidently much higher than that in the control group (8/33,P<0.05), suggesting that the efficacy of ZY-4 is superior to that of placebo in elevating CD 4 + count. Moreover, ZY-4 showed actions in elevating CD45RA+ and CD 8 + count, reducing HIV virus load, improving clinical symptom/sign and increasing body weight of patients. No obvious adverse reaction was found in the clinical trial.Conclusion: ZY-4 has an immunity-protective and/or rebuilding function in HIV/AIDS patients in the early and middle stage, and also shows effects in lowering viral load, increasing body weight and improving symptoms and signs to a certain degree.
- John G Bartlett, Joel E Callant. Diagnosis and treatment of HIV infection. Beijing: Science Publication Press, 2002: 2.
- Su CL. Primary research of clinical treatment of AIDS. J Tradit Chin Med 1990;31(2): 26–29.
- Jiang XY. The pathogenesis of AIDS. J Chin Med 2001; 16(6): 41–42.
- Huang BS. The treatment of AIDS with TCM. Harbin: Heilongjiang Science and Technology Publishing House, 1990: 25.
- Xue BS. The knowledge of HIV/AIDS with TCM theory. J Tradit Chin Med 1991;32(1): 20.
- Yang FZ, Yan JH. Exploring Yuan Qi theory in HIV/AIDS. J Basic Theory Tradit Chin Med 2003; 9(8): 4–5.
- Yang FZ. Wang J. Developing research of HIV/AIDS in the TCM pathogenesis. J Inform Tradit Chin Med 2004; 11 (4): 365–367.
- Zhao WS. Present clinical immunology. Beijing: People’s Miltary Publication Press, 1994: 683–686.
- Lu WB, editor. Preventing and treating HIV/AIDS. Beijing: People’s Medical Publishing Hourse, 1994: 170–181.
- Jian TJ, Zhao M.Wang J, et al. Clinical research of liver damage of HIV complicated with HCV infection. J New Chin Materia Med 2004; 3(4): 22–24.
- Yang FZ, Wang J, Zhao M, et al. The relativity research of traditional Chinese medicine syndromes and T lymphocyte and virus loading. China J Tradit Chin Med Pharmacy 2004: 19(12): 733–737.
- Randomized double-blinded and controlled clinical trial on treatment of HIV/AIDS by Zhongyan-4
Chinese Journal of Integrative Medicine
Volume 12, Issue 1 , pp 6-11
- Cover Date
- Print ISSN
- Online ISSN
- Chinese Association of Traditional and Western Medicine, China Academy of Chinese Medical Sciences
- Additional Links
- principle for supplementing Qi
- nourishing Yin
- clearing heat and detoxication
- T-Iymphocyte subsets
- HIV viral load
- Industry Sectors
- Author Affiliations
- 1. Department of AIDS, Institute of Basic Theory, China Academy of Chinese Medical Sciences, 100700, Beijing
- 2. The 302 Hospital of PLA, China